問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
China Medical University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2023-03-01 - 2026-12-31
Condition/Disease
Relapsed or Resistant Acute Leukaemias
Test Drug
LBS-007
Participate Sites3Sites
Recruiting3Sites
2010-09-01 - 2011-08-31
Participate Sites1Sites
Terminated1Sites
2011-03-01 - 2013-05-31
Participate Sites2Sites
Terminated2Sites
2024-06-30 - 2029-06-30
Participate Sites8Sites
Recruiting8Sites
2021-08-01 - 2024-08-01
Recruiting1Sites
2019-06-01 - 2023-05-31
Intracerebral haemorrhage (ICH)
Tranexamic acid
2013-12-15 - 2016-12-31
anginal
Dantonic®
Participate Sites7Sites
Terminated7Sites
2016-06-13 - 2020-12-31
Participate Sites4Sites
Terminated3Sites
Study ended1Sites
Division of Orthopedics
2012-05-01 - 2018-12-03
Acute Ischaemic Stroke
Tissue Plasminogen Activator (tPA)
Participate Sites9Sites
Suspended8Sites
Division of Neurology
2021-03-01 - 2027-04-01
全部
